Prosaposin is a regulator of progranulin levels and oligomerization
Increasing progranulin (PGRN) levels is a promising approach for treating frontotemporal dementia and other neurodegenerative diseases. Here Nicholson et al.show that the prosaposin (PSAP) locus is associated with plasma PGRN levels and demonstrate that PSAP can alter PGRN levels and its oligomeriza...
Guardado en:
Autores principales: | Alexandra M. Nicholson, NiCole A. Finch, Marcio Almeida, Ralph B. Perkerson, Marka van Blitterswijk, Aleksandra Wojtas, Basar Cenik, Sergio Rotondo, Venette Inskeep, Laura Almasy, Thomas Dyer, Juan Peralta, Goo Jun, Andrew R. Wood, Timothy M. Frayling, Christian Fuchsberger, Sharon Fowler, Tanya M. Teslovich, Alisa K. Manning, Satish Kumar, Joanne Curran, Donna Lehman, Goncalo Abecasis, Ravindranath Duggirala, Cyril Pottier, Haaris A. Zahir, Julia E. Crook, Anna Karydas, Laura Mitic, Ying Sun, Dennis W. Dickson, Guojun Bu, Joachim Herz, Gang Yu, Bruce L. Miller, Shawn Ferguson, Ronald C. Petersen, Neill Graff-Radford, John Blangero, Rosa Rademakers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69727bed9cd74c41b1fff7349a1c4efe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations
por: Xiaolai Zhou, et al.
Publicado: (2017) -
Decrease in prosaposin in the Dystrophic mdx mouse brain.
por: Hui-Ling Gao, et al.
Publicado: (2013) -
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.
por: Daniela Galimberti, et al.
Publicado: (2012) -
Increased Fat Taste Preference in Progranulin-Deficient Mice
por: Lana Schumann, et al.
Publicado: (2021) -
Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases
por: Lan YJ, et al.
Publicado: (2021)